7 research outputs found

    DETERMINACIÓN DE COMPUESTOS CON ACTIVIDAD ANTIOXIDANTE EN PRODUCTOS UNTABLES DE FRESA (vc. Camarosa)

    Full text link
    El actual ritmo de vida, hace que cada vez más, el consumidor esté interesado en poder disponer de productos elaborados a base de fruta con azúcar que mantengan las propiedades beneficiosas de los productos frescos de los que proceden y que no provoquen los efectos indeseables como la caries y diabetes. En este sentido, los untables de fresa, elaborados con isomaltulosa (edulcorante de bajo índice glicérico) es un producto interesante que responde a estas exigencias. El presente trabajo tiene como principal objetivo evaluar en productos untables de fresa la influencia del tratamiento osmótico (vía húmeda o seca) con posterior tratamiento térmico (100ºC durante 0, 10 ó 30 min) en la presencia de compuestos con actividad antioxidante. Se ha demostrado que el tipo de deshidratación osmótica aplicado en la obtención de estos productos untables influye significativamente en el nivel detectado de todos los compuestos analizados (ácido p-cumárico, ácido elágico, ácido gálico, kaempferol y pelargonidina) con excepción del ácido cafeico. Sin embargo no se observaron diferencias con relación al tiempo de tratamiento térmico aplicado. Un análisis multivariante (PCA) reflejó que todos los compuestos excepto la pelargonidina presentaron un comportamiento semejante, con valores más altos en los tratamientos por vía seca que en los de vía húmeda.Villegas Castro, N. (2009). DETERMINACIÓN DE COMPUESTOS CON ACTIVIDAD ANTIOXIDANTE EN PRODUCTOS UNTABLES DE FRESA (vc. Camarosa). http://hdl.handle.net/10251/14367Archivo delegad

    Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

    Get PDF
    Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

    Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study (Intensive Care Medicine, (2021), 47, 2, (160-169), 10.1007/s00134-020-06234-9)

    No full text
    The original version of this article unfortunately contained a mistake. The members of the ESICM Trials Group Collaborators were not shown in the article but only in the ESM. The full list of collaborators is shown below. The original article has been corrected
    corecore